Skip to main content
MRCGP International AKT🇵🇰 MCPS Family Medicine (CPSP) 100% Free

Biostatistics & EBM
for MRCGP AKT & MCPS

The complete free biostatistics revision guide for MRCGP International AKT (evidence domain — 10% of paper) and MCPS Family Medicine Part I. Formula sheets, worked AKT-style examples, study design hierarchy, and GRADE evidence — all in one place.

20
AKT Evidence Questions
5–8%
MCPS Blueprint Share
18
Key Formulas
3
Worked AKT Examples

MRCGP International AKT

Evidence Domain — 10% of paper

The AKT evidence interpretation domain accounts for approximately 20 of 200 questions. This is the domain where most candidates lose easy marks — not because the content is hard, but because they don't revise it systematically. A candidate who scores 90% on clinical questions but only 50% on evidence questions loses 10 marks compared to someone who scores 80% on both.

NNT, ARR, RRR calculations
Sensitivity, specificity, PPV, NPV
Forest plot interpretation
GRADE evidence quality
Study design hierarchy
p-values and confidence intervals
🇵🇰

MCPS Family Medicine Part I

Research Methodology — 5–8% of paper

The CPSP blueprint explicitly lists Research Methodology and Biostatistics as a core component of MCPS Part I. With 200 questions in the paper, this translates to 10–16 questions. Candidates who master this section gain a reliable advantage — these questions are more predictable than clinical scenarios.

Study designs (RCT, cohort, case-control)
Sensitivity and specificity
NNT and ARR
Relative risk vs odds ratio
Incidence vs prevalence
p-values and confidence intervals
Exam Formula Sheet

18 Formulas You Must Know

Every formula tested in the MRCGP AKT evidence domain and MCPS biostatistics section. Memorise these before your exam.

Diagnostic Test Accuracy

Sensitivity
TP ÷ (TP + FN)

SnNout — rules OUT if negative

Specificity
TN ÷ (TN + FP)

SpPin — rules IN if positive

PPV
TP ÷ (TP + FP)

Rises with higher prevalence

NPV
TN ÷ (TN + FN)

Falls with higher prevalence

LR+
Sensitivity ÷ (1 − Specificity)

>10 = strong rule-in

LR−
(1 − Sensitivity) ÷ Specificity

<0.1 = strong rule-out

Risk & Effect Measures

ARR
CER − EER

Absolute Risk Reduction

NNT
1 ÷ ARR

Number Needed to Treat

RRR
ARR ÷ CER

Relative Risk Reduction (can mislead)

RR
Risk(exposed) ÷ Risk(unexposed)

Cohort studies & RCTs

OR
Odds(cases) ÷ Odds(controls)

Case-control studies

ARI / NNH
EER − CER / 1 ÷ ARI

Absolute Risk Increase / NNH

Epidemiology

Incidence Rate
New cases ÷ Population at risk × Time

Measures risk

Prevalence
All cases ÷ Total population

Point or period

Relationship
Prevalence ≈ Incidence × Duration

Key exam formula

Attack Rate
Cases ÷ Exposed population × 100

Outbreak investigations

Attributable Risk
Incidence(exposed) − Incidence(unexposed)

Excess risk from exposure

PAR%
(Total incidence − Unexposed incidence) ÷ Total incidence

Population Attributable Risk

Evidence Hierarchy

Study Design Hierarchy

Know which study design answers which research question — and which statistical measure goes with each design.

Study DesignResearch QuestionMeasure
Systematic Review / Meta-analysisWhat is the overall effect across all studies?Pooled RR / OR / MD
Randomised Controlled Trial (RCT)Does treatment X cause outcome Y?RR, ARR, NNT
Cohort StudyDoes exposure X lead to outcome Y over time?RR, Incidence Rate
Case-Control StudyWhat exposures are associated with this disease?Odds Ratio (OR)
Cross-Sectional StudyWhat is the prevalence of X in this population?Prevalence, Sensitivity/Specificity
Case Report / SeriesWhat happened in this patient/group?Descriptive only
Exam Practice

Worked AKT & MCPS Examples

Step-by-step solutions to the types of biostatistics questions that appear in every MRCGP AKT and MCPS sitting.

AKT-Style: NNT Calculation

Risk Measures

Clinical Scenario

A trial of rosuvastatin in primary prevention shows MI occurs in 3.2% of the treatment group vs 5.8% in the placebo group over 5 years. What is the NNT?

Step-by-Step Solution

1ARR = CER − EER = 5.8% − 3.2% = 2.6% = 0.026
2NNT = 1 ÷ ARR = 1 ÷ 0.026 = 38.5 ≈ 39
3RRR = ARR ÷ CER = 2.6% ÷ 5.8% = 44.8%

Answer & Clinical Interpretation

NNT = 39. You need to treat 39 patients for 5 years to prevent 1 MI. The RRR of 45% sounds impressive — but the NNT of 39 gives the clinically meaningful picture.

Evidence Quality

GRADE Evidence Framework

Used by NICE, WHO, and all major guidelines. The MRCGP AKT tests GRADE — know the four levels and what downgrades evidence.

High

Further research very unlikely to change confidence in the estimate. Typically well-conducted RCTs.

RCTs start here

Moderate

Further research likely to have important impact on confidence. Downgraded RCTs or upgraded observational studies.

Downgraded RCTs

Low

Further research very likely to have important impact. Observational studies typically start here.

Observational studies

Very Low

Any estimate of effect is very uncertain. Case reports, expert opinion, or heavily downgraded studies.

Case reports / opinion

5 Reasons Evidence Gets Downgraded in GRADE

1

Risk of Bias

Poor allocation concealment, lack of blinding, high dropout

2

Inconsistency

Heterogeneous results across studies (high I²)

3

Indirectness

Different population, intervention, or outcome from question

4

Imprecision

Wide confidence intervals, small sample size

5

Publication Bias

Funnel plot asymmetry, selective reporting

Common Questions

Biostatistics FAQ for MRCGP & MCPS

Ready to Master Biostatistics?

Use GPManual's interactive biostatistics module to practice 2×2 table calculations, likelihood ratios, and forest plot interpretation — with instant feedback and worked solutions.